Feedback on Evolving Patient Group Input Submissions into the Drug Reimbursement Review Process

To provide written feedback, please complete the following form and submit it by 5:00 p.m. ET on June 5, 2025. Individuals and organizations must identify themselves by name on the template for their feedback to be considered valid.

To ensure we engage with a diverse range of perspectives, we kindly ask that each patient group designate only 1 representative to provide feedback. This will help us include as many voices as possible in our considerations.

Contact Information

Your First Name

Your Last Name

Your Email

If you are submitting feedback on behalf of a patient organization:

Organization providing feedback:

Corporate Contact's First Name

Corporate Contact's Last Name

Corporate Contact 's Title:

Corporate Contact 's Email:

If you or your organization are not submitting feedback on a section, please indicate: No relevant feedback to submit.

Questions for Feedback

1. Input for the Deliberative Framework

In this section we are interested in exploring WHAT information from the patient perspective is provided and how to focus it on what is needed to support reimbursement review deliberations.

1.1 What suggestions do you have for evolving the patient input process to focus on what is needed to support deliberations on the deliberative framework domains?

2. Input Collection and Submission Methods

In this section we are interested in exploring HOW patient input is collected and submitted.

2.1 What are your ideas and suggestions for methods (e.g., surveys, interviews, focus groups, videos, other) you think work well to collect patient perspectives? Please explain why.

2.2 What are your ideas and suggestions for formats (e.g., written input template, verbal input, targeted input questions, open-ended questions, broad questions, a combination of these) you think work well to submit patient group input? Please explain why.

3. Input Submission Communication and Guidance

In this section we are interested in learning about the support tools, resources, and communication that can support patient group input submissions.

3.1 What guidance, communication, or tools would make the input process easier for you (e.g., video guide[s], learning sessions, guidance document, tool kit, other)?

3.2 What type of feedback would you like to receive on your input submission?

3.3 How would you like to receive feedback on your input submission?

4. Other

In this section we are interested in learning about other considerations for evolving patient group input into drug reimbursement reviews.